Upgrade to SI Premium - Free Trial

Cytokinetics (CYTK) PT Raised to $106 at Truist Securities

May 6, 2026 7:11 AM
(Updated - May 6, 2026 9:22 AM EDT)

Truist Securities analyst Srikripa Devarakonda raised the price target on Cytokinetics ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change